TCD spin-out Biologit raises €1 million from investors | Business Post

  • 📰 businessposthq
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 71%

Business News News

Business Business Latest News,Business Business Headlines

TCD spin-out Biologit raises €1 million from investors, ChasTaylor reports.

Biologit, an Irish tech company focused on drug safety, has raised €1 million from investors.

Gerard Ryan, founder of Longboat Clinical, a clinical trials platform, David Shanahan, a life sciences veteran, and Enterprise Ireland have all lined up to back the Trinity College spin-out. Founded by Nicole Baker and Bruno Ohana in 2019, the company has developed an artificial intelligence-powered platform that monitors scientific and medical literature to provide up-to-date information for clinical safety and pharmacovigilance.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 8. in BUSİNESS

Business Business Latest News, Business Business Headlines